Abstract:Objective:To observe the expression characteristics of peripheral blood monocytes and lymphocytes in patients with smear negative pulmonary tuberculosis (SNPT) and to explore the clinical value of the combined detection with T-cell spot test of tuberculosis (T-SPOT.TB) in the diagnosis and differential diagnosis of SNPT, so as to provide new indicators for its early diagnosis.Methods:A total of 134 patients with SNPT, 56 patients with lung cancer and 95 patients with pneumonia hospitalized in Beijing Chest Hospital, Capital Medical University from January 2018 to December 2018 were enrolled in the study.The data of monocytes, lymphocytes and the ratio of monocytes to lymphocytes (ML ratio) in peripheral blood and T-SPOT.TB and related clinical information in three groups were collected and retrospectively analyzed.We selected the statistically different indicators of three groups and used sensitivity, specificity, misdiagnosis rate, missed diagnosis rate and diagnostic accuracy to evaluate the diagnosis and differential diagnosis of SNPT, lung cancer, and pneumonia by alone or in combination with T-SPOT.TB.Results:(1)The percentage of M [(8.96±2.46)%] and ML ratio (0.36±0.19) in the SNPT group were significantly higher than those in the lung cancer group [(7.06±1.34)% and 0.30±0.13, respectively] and pneumonia group [(8.17±2.13)% and 0.31±0.18, respectively], while the number of white blood cells [(5.86±1.75)×10 9/L] was significantly lower than that in the lung cancer group [(6.88±1.76)×10 9/L] and the value of L [(1.57±0.54)×10 9/L] was significantly lower than that in the pneumonia group [(1.87±0.67)×10 9/L] ( P<0.05). (2)In the differential diagnosis of SNPT and lung cancer, the specificity (87.50%) and misdiagnosis rate (12.50%) of the percentage of M were better than ML ratio (17.86% and 82.14%, respectively) and T-SPOT.TB (67.86% and 32.14%, respectively). The sensitivity of ML ratio (88.81%) was close to that of T-SPOT.TB (87.31%). As for the differential diagnosis of SNPT and pneumonia, the sensitivity of ML ratio (88.81%) was higher than that of the percentage of M (66.42%), which was close to that of T-SPOT.TB (87.31%), but its specificity (28.42%) was lower than that of T-SPOT.TB (63.16%) and percentage of M (56.84%). (3)The sensitivity of percentage of M combined with T-SPOT.TB (parallel) and ML ratio combined with T-SPOT.TB (parallel) were 97.01% and 99.25%, and their missed diagnosis rate were 2.99% and 0.75%, respectively, for the auxiliary diagnosis of SNPT.In the differential diagnosis between SNPT and lung cancer, the specificity and misdiagnosis rate of percentage of M combined with T-SPOT.TB (series) were 94.64% and 5.36%, respectively.In the differential diagnosis between SNPT and pneumonia, the specificity of percentage of M and ML ratio combined with T-SPOT.TB (series) were 82.11% and 70.53%, respectively, and their misdiagnosis rate were 17.89% and 29.47%, respectively. Conclusions:The combined detection of percentage of M and ML ratio combined with T-SPOT.TB has potential clinical value for the differential diagnosis of SNPT, lung cancer and pneumonia, which provides a simple, practicable and cheap method.It can be used as selected indicators of auxiliary diagnosis of SNPT according to the clinical needs.

Clinical value of peripheral blood monocytes related indicators alone or in combination with T-SPOT.TB in the diagnosis of smear negative pulmonary tuberculosis

Exploration of the clinical value of peripheral blood monocytes related indicators combined with T-SPOT.TB in the auxiliary diagnosis of smear negative pulmonary tuberculosis

Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients

The Diagnostic Value of T-cell Enzyme-linked Immunosorbent Spot Assay in Tuberculous Pleurisy

Diagnostic utility of pleural fluid T-SPOT and interferon-gamma for tuberculous pleurisy: A two-center prospective cohort study in China

Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

[Evaluation of T-SPOT.TB assay in the diagnosis of pulmonary tuberculosis within different age groups].

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-infected Patients in China.

Evaluation of T-SPOT.TB test in differential diagnosis between active tuberculosis and nontuberculous mycobacterial disease

Diagnostic value of T cells spot test of tuberculosis infection on blood and cerebrospinal fluid for tuberculous meningitis

Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease

T-SPOT Combined with CT Image Analysis Based on Deep Learning for Early Differential Diagnosis of Non-Tuberculous Mycobacteria Pulmonary Disease and Pulmonary Tuberculosis.

Comparative Analysis of the Results of Tuberculosis Antibody IgM and Peripheral Blood T-SPOT.TB Test in 289 Cases of Patients with Tuberculosis

The Performance and Limitation of T-SPOT.TB for the Diagnosis of TB in a High Prevalence Setting.

[Diagnostic Value and Influencing Factors of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Combined with Xpert MTB/RIF for Intrathoracic Lymph Node Tuberculosis].

Diagnostic Value of T-SPOT.TB Assay for Tuberculous Peritonitis: A Meta-Analysis

Using TBAg/PHA Ratio for Monitoring TB Treatment: A Prospective Multicenter Study.

Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research

Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting

Diagnostic Performance of a Novel Mycobacterium Tuberculosis Specific T-Cell Based Assay for Tuberculosis